|
|
||||||||
1 Division of Respiratory Medicine, Dept of Medicine and Geriatrics, United Christian Hospital, and 2 Dept of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
CORRESPONDENCE: C. M. Chu, Division of Respiratory Medicine, Dept of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China. Fax: 852 35135548. E-mail: chucm@ha.org.hk
Keywords: Infectivity, RT-PCR, severe acute respiratory syndrome, severe acute respiratory syndrome-associated coronavirus, transmission
Received: May 14, 2004
Accepted August 16, 2004
Severe acute respiratory syndrome (SARS) is a highly infectious respiratory infection with a high mortality. The duration of infectivity is unknown. The RT-PCR positivity for SARS-associated coronavirus (SARS-CoV) was followed in 45 virologically confirmed SARS patients.
Serial RT-PCRs for SARS-CoV were performed in the nasopharyngeal aspirate, stool and urine of 45 SARS patients who survived until discharge. All patients had at least one site that was positive for SARS-CoV on presentation. Time to RT-PCR conversion was studied in all patients.
There were 15 males (33.3%) and 30 females (66.7%), with a mean±SD age of 40.7±14.7 yrs. The median (range) time of RT-PCR conversion was 30 days (281). On discharge from the hospital, 18 (40%) remained RT-PCR positive in at least one site. For patients with positive RT-PCR on discharge, the median (range) time to RT-PCR conversion after discharge was 13 days (260).
A significant proportion of severe acute respiratory syndrome patients remained RT-PCR positive for severe acute respiratory syndrome-associated coronavirus for a substantial duration after discharge. The clinical significance is unknown and this finding merits further study. It is prudent to advise patients to adhere to strict personal hygiene on discharge until RT-PCR becomes negative.
This article has been cited by other articles:
![]() |
V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |